About the Role
Lead and build the Clinical Operations function as a key member of the development team. Report to the Chief Medical Officer, ensuring studies are completed on time and within budget, aligning with corporate objectives. This hands-on role requires building strong relationships with internal and external groups. Contribute to an entrepreneurial environment, making a meaningful impact on clinical trial progress for novel gene therapies.
Responsibilities
- Collaborate with Lexeo CMO, R&D leadership, Weill Cornell research staff, Lexeo clinical, quality, and regulatory colleagues, CRO partners, and other vendors to conduct clinical trials meeting corporate goals
- Evaluate and develop optimal outsourcing models for trial implementation, including selecting CROs and external partners
- Oversee development of requests for proposals, negotiate and approve contracts and work orders, and review invoices for approval
- Develop, maintain, and report on program budgets, including long-range forecasting, to support Lexeo’s financial goals
- Monitor study-specific timelines and key deliverables, implementing strategies to optimize trial conduct efficiency
- Provide oversight of CROs to prevent issues or rapidly adapt to challenges in feasibility/start-up, recruitment, resourcing, and site management
Skills
- Thorough knowledge of development program management from IND- through NDA/BLA, including inspection readiness
- Advanced working knowledge of all relevant guidelines, including ICH, GCP, FDA
- Excellent communication skills
- Ability to influence across multiple functions
Location
- New York City office
- Remote
Work Type
- Hybrid model
- 2 days/week in office
- 3 days working from home
Experience Level
- 10+ years of experience in the pharmaceutical or biotech industry within clinical operations and trial management
- Experience leading global clinical trials
- Rare disease/gene therapy trial experience preferred
- Extensive experience in CRO/vendor selection and oversight
- Extensive experience in budget projection and management
- Extensive experience in establishing clear milestones
- Extensive experience in ensuring high-quality data delivery and report generation
- Experience working in a fast-paced environment
Education Level
- Advanced degree preferred
Salary/Compensations
- $300,000 - $350,000 a year
- Compensation is dependent on qualifications and experience
About the Company
- Lexeo Therapeutics is a clinical-stage genetic medicine company headquartered in New York City
- Pioneering cardiac genetic medicine candidates to treat the root causes of inherited cardiovascular diseases
- Lead program, LX2006, targets cardiomyopathy associated with Friedreich’s Ataxia
- Broader pipeline addresses genetically defined conditions such as hypertrophic and arrhythmogenic cardiomyopathies
- Backed by a strong financial foundation, Lexeo is positioned to translate groundbreaking science into durable clinical impact
Equal Opportunity
- Lexeo Therapeutics is an EEO employer committed to an exciting, diverse, and enriching work environment
